{"id":3086,"date":"2020-08-28T16:16:00","date_gmt":"2020-08-28T16:16:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=3086"},"modified":"2025-01-14T22:00:04","modified_gmt":"2025-01-14T22:00:04","slug":"progress-toward-hepatitis-b-and-hepatitis-c-elimination-using-a-catalytic-funding-model-tashkent-uzbekistan-december-6-2019-march-15-2020","status":"publish","type":"post","link":"https:\/\/cdafound.org\/zh\/progress-toward-hepatitis-b-and-hepatitis-c-elimination-using-a-catalytic-funding-model-tashkent-uzbekistan-december-6-2019-march-15-2020\/","title":{"rendered":"\u5229\u7528\u50ac\u5316\u878d\u8d44\u6a21\u5f0f\u63a8\u8fdb\u6d88\u9664\u4e59\u809d\u548c\u4e19\u809d\u8fdb\u7a0b\u2014\u2014\u4e4c\u5179\u522b\u514b\u65af\u5766\u5854\u4ec0\u5e72\uff0c2019\u5e7412\u67086\u65e5\u81f32020\u5e743\u670815\u65e5"},"content":{"rendered":"<h2 class=\"wp-block-heading\">\u6982\u62ec<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">2016 \u5e74\uff0c\u4e16\u754c\u536b\u751f\u7ec4\u7ec7 (WHO) \u8bbe\u5b9a\u4e86\u5230 2030 \u5e74\u5728\u5168\u7403\u8303\u56f4\u5185\u5c06\u53d1\u75c5\u7387\u964d\u4f4e 90%\u3001\u5c06\u6b7b\u4ea1\u7387\u964d\u4f4e 65% \u7684\u6d88\u9664\u809d\u708e\u76ee\u6807 (1)\u3002\u4e4c\u5179\u522b\u514b\u65af\u5766\u7684\u4e59\u809d\u75c5\u6bd2 (HBV) \u548c\u4e19\u809d\u75c5\u6bd2 (HCV) \u611f\u67d3\u7387\u5f88\u9ad8\uff0c\u4f46\u8be5\u56fd\u7f3a\u4e4f\u5b9e\u73b0\u4e16\u536b\u7ec4\u7ec7\u76ee\u6807\u7684\u8d44\u91d1\u3002\u7531\u4e8e\u7f3a\u4e4f\u7528\u4e8e\u6d88\u9664 HBV \u548c HCV \u611f\u67d3\u7684\u5927\u578b\u8d22\u653f\u6350\u52a9\u9879\u76ee\uff0c\u8d44\u91d1\u4e0d\u8db3\u662f\u4e4c\u5179\u522b\u514b\u65af\u5766\u548c\u5176\u4ed6\u4e2d\u4f4e\u6536\u5165\u56fd\u5bb6\u5b9e\u73b0\u8fd9\u4e9b\u76ee\u6807\u7684\u91cd\u8981\u969c\u788d\u30022019 \u5e74 12 \u6708\uff0c\u5728\u4e4c\u5179\u522b\u514b\u65af\u5766\u5854\u4ec0\u5e72\u542f\u52a8\u4e86\u4e00\u9879\u91c7\u7528\u50ac\u5316\u878d\u8d44\u6a21\u5f0f\u7684\u8bd5\u70b9\u9879\u76ee\uff0c\u5305\u62ec\u7b80\u5316\u7684\u68c0\u6d4b\u548c\u6cbb\u7597\u7b56\u7565\u3002\u50ac\u5316\u878d\u8d44\u662f\u4e00\u79cd\u673a\u5236\uff0c\u901a\u8fc7\u8fd9\u79cd\u673a\u5236\uff0c\u4e00\u4e2a\u9879\u76ee\u7684\u603b\u6210\u672c\u7531\u591a\u4e2a\u8d44\u91d1\u6765\u6e90\u652f\u4ed8\uff0c\u4f46\u542f\u52a8\u65f6\u7684\u9884\u4ed8\u8d44\u672c\u8fdc\u4f4e\u4e8e\u9879\u76ee\u603b\u6210\u672c\u3002\u6301\u7eed\u7684\u8d39\u7528\uff08\u5305\u62ec\u68c0\u6d4b\u548c\u6cbb\u7597\u8d39\u7528\uff09\u7531\u53c2\u4e0e\u8be5\u8ba1\u5212\u7684 80% \u60a3\u8005\u652f\u4ed8\uff0c\u8fd9\u4e9b\u60a3\u8005\u53ea\u9700\u652f\u4ed8\u5c11\u91cf\u8d39\u7528\u5373\u53ef\u8d2d\u4e70\u836f\u7269\uff0c\u8865\u8d34 20% \u65e0\u6cd5\u627f\u62c5\u6cbb\u7597\u8d39\u7528\u4ece\u800c\u83b7\u5f97\u514d\u8d39\u836f\u7269\u7684\u60a3\u8005\u3002\u8fd9\u9879\u4e3a\u671f 1 \u5e74\u7684\u8bd5\u70b9\u8ba1\u5212\u8bbe\u5b9a\u7684\u76ee\u6807\u662f\u68c0\u6d4b 250,000 \u540d\u6210\u4eba\u7684 HBV \u548c HCV \u611f\u67d3\u60c5\u51b5\uff0c\u5e76\u6cbb\u7597\u6240\u6709\u6d3b\u52a8\u6027\u611f\u67d3\u60a3\u8005\uff0c\u5305\u62ec\u4e59\u809d\u8868\u9762\u6297\u539f (HBsAg) \u68c0\u6d4b\u7ed3\u679c\u5448\u9633\u6027\u7684\u60a3\u8005\u548c HCV \u6838\u5fc3\u6297\u539f\u68c0\u6d4b\u7ed3\u679c\u5448\u9633\u6027\u7684\u60a3\u8005\u3002\u5728\u8be5\u8ba1\u5212\u5b9e\u65bd\u7684\u524d 3 \u4e2a\u6708\uff0c\u5171\u6709 24,821 \u4eba\u63a5\u53d7\u4e86 HBV \u548c HCV \u611f\u67d3\u68c0\u6d4b\u3002\u5728\u63a5\u53d7\u68c0\u6d4b\u7684\u4eba\u7fa4\u4e2d\uff0c1,084 \u4eba\uff084.4%\uff09\u7684 HBsAg \u68c0\u6d4b\u7ed3\u679c\u5448\u9633\u6027\uff0c1,075 \u4eba\uff084.3%\uff09\u7684 HCV \u6297\u4f53\uff08\u6297-HCV\uff09\u68c0\u6d4b\u7ed3\u679c\u5448\u9633\u6027\u3002\u5728\u611f\u67d3\u8005\u4e2d\uff0c275\u4eba\uff0825.4%\uff09\u5f00\u59cb\u63a5\u53d7\u4e59\u809d\u75c5\u6bd2\uff08HBV\uff09\u6cbb\u7597\uff0c163\u4eba\uff0815.2%\uff09\u5f00\u59cb\u63a5\u53d7\u4e19\u809d\u75c5\u6bd2\uff08HCV\uff09\u6cbb\u7597\uff0c\u5176\u4e2d86.5%\u4eba\u81ea\u8d39\u6cbb\u7597\uff0c13.5%\u4eba\u514d\u8d39\u83b7\u5f97\u836f\u7269\u3002\u65e9\u671f\u7ed3\u679c\u8868\u660e\uff0c\u5982\u679c\u8d39\u7528\u8f83\u4f4e\uff0c\u60a3\u8005\u613f\u610f\u81ea\u8d39\u6cbb\u7597\uff0c\u8fd9\u53ef\u4ee5\u62b5\u6d88\u6d88\u9664\u6210\u672c\u3002\u7136\u800c\uff0c\u9700\u8981\u6539\u8fdb\u6574\u4e2a\u533b\u7597\u4f53\u7cfb\u4ee5\u6536\u56de\u524d\u671f\u6295\u8d44\u3002\u8be5\u9879\u76ee\u7684\u7ecf\u9a8c\u6559\u8bad\uff0c\u5305\u62ec\u4f7f\u7528\u7b80\u5316\u7684\u68c0\u6d4b\u548c\u6cbb\u7597\u6307\u5357\u3001\u5168\u79d1\u533b\u751f\u4ee3\u66ff\u4e13\u79d1\u533b\u751f\u4ee5\u53ca\u521b\u65b0\u878d\u8d44\u65b9\u5f0f\u4ee5\u964d\u4f4e\u6210\u672c\u7684\u6709\u6548\u6027\uff0c\u53ef\u4ee5\u6307\u5bfc\u5176\u4ed6\u56fd\u5bb6\u5f00\u5c55\u7c7b\u4f3c\u4e3e\u63aa\uff0c\u5e76\u6709\u52a9\u4e8e\u904f\u5236\u75c5\u6bd2\u6027\u809d\u708e\u7684\u5168\u7403\u6d41\u884c\uff0c\u5c24\u5176\u662f\u5728\u4e2d\u4f4e\u6536\u5165\u56fd\u5bb6\u3002<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u56fd\u5bb6\uff1a<\/strong> \u4e4c\u5179\u522b\u514b\u65af\u5766<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link has-text-color wp-element-button\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32853186\/\" style=\"border-radius:6px;color:#951b23\" target=\"_blank\" rel=\"noreferrer noopener\">\u9605\u8bfb\u5b8c\u6574\u62a5\u544a<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Summary In 2016, the World Health Organization (WHO) set hepatitis elimination targets of 90% reduction in incidence and 65% reduction in mortality worldwide by 2030 (1). Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection prevalences are high in Uzbekistan, which lacks funding for meeting WHO\u2019s targets. In the absence of large financial donor [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":3158,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[31,21,10],"publication-author":[659,657,663,658,662,661,665,494,664,660],"class_list":["post-3086","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-elimination","tag-hbv","tag-hcv","publication-author-averhoff-f","publication-author-bakieva-s","publication-author-brigida-k","publication-author-dunn-r","publication-author-kamili-s","publication-author-musabaev-e","publication-author-nasrullah-m","publication-author-razavi-h","publication-author-razavi-shearer-k","publication-author-sadirova-s"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/posts\/3086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/comments?post=3086"}],"version-history":[{"count":5,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/posts\/3086\/revisions"}],"predecessor-version":[{"id":7460,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/posts\/3086\/revisions\/7460"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/media\/3158"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/media?parent=3086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/categories?post=3086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/tags?post=3086"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/zh\/wp-json\/wp\/v2\/publication-author?post=3086"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}